SRRK Scholar Rock Inc.: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Simbol resmi perusahaan Scholar Rock Holding Corporation (SRRK)

The quarterly earnings per share growth chart allows for an assessment of the business model efficiency of Scholar Rock (SRRK), which is based on US R&D centers and contract manufacturing. By comparing the chart on GURU.Markets, we see how management focuses on clinical data, while the 9.70 metric determines the status of the yield parameter. The team is successfully adapting internal processes for commercialization, leveraging positive late-stage research results.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Scholar Rock Holding Corporation (SRRK): kanggo periode 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Scholar Rock

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:scholarrock.com, SRRK
Produk asil prodhuksi Scholar Rock Inc.

This indicator measures the percentage change in net earnings per share compared to the same quarter of the previous year. Analyzing this trend allows for an assessment of capital management efficiency and business scaling rates. By tracking the quarterly EPS growth rate, an investor can observe the actual speed of change in operating profitability. For Scholar Rock (SRRK), the negative trend reflects the systematic cash burn associated with costly clinical trials. The current earnings deficit is logically driven by the absence of commercial drug sales.

Analisis perusahaan pesaing

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|CNTA: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Dyne Therapeutics (DYN)|EWTX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Rapport Pharma RAPP|Alumis Pharma - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ZVRA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Contineum Therapeutics, Inc.|LRMR: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Capricor Therapeutics CAPR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TRDA|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Channel PTHS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MediciNova Inc. (MNOV)|SER - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Apimeds Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan AEON Biopharma, Inc.|NLSP (NLS Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BNOX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan FSD Pharma|Wutah bathi EPS kuartalan Reata